COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000 CIHR Ontario 2021 Read More